Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,431,828,055    

Indirect Value

   $7,287,641,839      
Total Shares   186,710,189      
Total Value   $9,719,469,894      


Neurocrine Biosciences Inc $700,861,962 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,848,614 Ligand Pharmaceuticals Inc $1,219,057,182 Curis Inc $3,390,252 Repligen Corp $457,615,775 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $700,861,962 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,848,614 Ligand Pharmaceuticals Inc $1,219,057,182 Curis Inc $3,390,252 Repligen Corp $457,615,775 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADLR Adolor Corp 10% Owner   –       –       •   2008-10-10 3 IO $0.00 $0 D/D 0 4,428,032 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-13 4 B $3.24 $157,305 I/I 48,500 4,428,032 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-14 4 B $3.15 $26,775 I/I 8,500 4,436,532 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-15 4 B $3.08 $156,983 I/I 51,000 4,487,532 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-16 4 B $3.12 $58,919 I/I 18,900 4,506,432 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-22 4 B $3.24 $231,372 I/I 71,400 4,577,832 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-23 4 B $3.22 $426,099 I/I 132,300 4,710,132 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-27 4 B $3.12 $201,192 I/I 64,400 4,774,532 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-28 4 B $2.75 $3,738,985 I/I 1,351,119 6,125,651 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-29 4 B $2.79 $157,632 I/I 56,400 6,182,051 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-30 4 B $2.94 $92,667 I/I 31,500 6,213,551 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-31 4 B $2.95 $2,950 I/I 1,000 6,214,551 1.42 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-07-25 4 B $8.99 $215,760 I/I 24,000 1,416,733 1.5 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-08-13 4 B $8.78 $189,585 I/I 21,600 1,438,333 1.5 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2005-01-13 4 S $15.40 $670,978 I/I (43,570) 985,163 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2005-08-11 4 S $11.92 $2,553,639 I/I (213,800) 1,224,533 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2006-01-12 4 S $15.69 $2,491,704 I/I (158,700) 1,116,433 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2006-01-13 4 S $15.40 $1,350,580 I/I (87,700) 1,028,733 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-10-17 4 S $7.69 $22,385,590 I/I (2,911,000) 2,259,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-12-31 4 S $6.20 $7,359,400 I/I (1,187,000) 1,684,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-09 4 S $6.30 $151,200 I/I (24,000) 1,672,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-14 4 S $6.05 $574,750 I/I (95,000) 1,626,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-20 4 S $6.00 $570,000 I/I (95,000) 1,580,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-21 4 S $6.00 $297,000 I/I (49,500) 1,556,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-06-18 4 S $5.52 $33,114 I/I (6,000) 1,502,351 -
  195  Records found
  1  2   3   4   5   6   7   8      
  Page 1 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us